Smith & Wesson Brands, Inc. (SWBI) Q3 2024 Earnings Call Transcript

Smith & Wesson Brands, Inc. (NASDAQ:SWBI) Q3 2024 Earnings Conference Call March 7, 2024 5:00 PM ET

Company Participants

Kevin Maxwell - General Counsel
Mark Smith - President and CEO
Deana McPherson - CFO

Conference Call Participants

Steve Dyer - Craig-Hallum

Operator

Good day, everyone, and welcome to Smith & Wesson Brands, Inc. Third Quarter Fiscal 2024 Financial Results Conference Call. [Operator Instructions] This call is being recorded.

At this time, I would turn the call over to Kevin Maxwell, Smith & Wesson's General Counsel, who will give us some information about the call.

Kevin Maxwell

Thank you, and good afternoon. Our comments today may contain forward-looking statements. Our use of the words anticipate, project, estimate, expect, intend, believe, and other similar expressions are intended to identify forward-looking statements. Forward-looking statements may also include statements on topics such as our product development, objectives, strategies, market share, demand, consumer preferences, inventory conditions for our products, growth opportunities and trends, and industry conditions in general.

Forward-looking statements represent our current judgment about the future and are subject to risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by our statements today. These risks and uncertainties are described in our SEC filings which are available on our website along with a replay of today's call. We have no obligation to update forward-looking statements.

We reference certain non-GAAP financial results. Our non-GAAP financial results exclude costs related to the move of our headquarters and certain of our operations to Tennessee and other costs. Reconciliations of GAAP financial measures to non-GAAP financial measures can be found in our SEC filings and in today's earnings press release, each of which is available on our website. Also, when we reference EPS, we are always referencing fully diluted EPS and any reference to EBITDAS is to